Literature DB >> 25877213

Oxidized LDL (oxLDL) activates the angiotensin II type 1 receptor by binding to the lectin-like oxLDL receptor.

Koichi Yamamoto1, Akemi Kakino2, Hikari Takeshita2, Norihiro Hayashi2, Lei Li2, Atsushi Nakano2, Hiroko Hanasaki-Yamamoto2, Yoshiko Fujita2, Yuki Imaizumi2, Serina Toyama-Yokoyama2, Chikako Nakama2, Tatsuo Kawai2, Masao Takeda2, Kazuhiro Hongyo2, Ryosuke Oguro2, Yoshihiro Maekawa2, Norihisa Itoh2, Yoichi Takami2, Miyuki Onishi2, Yasushi Takeya2, Ken Sugimoto2, Kei Kamide2, Hironori Nakagami2, Mitsuru Ohishi1, Theodore W Kurtz2, Tatsuya Sawamura2, Hiromi Rakugi2.   

Abstract

The angiotensin II type 1 receptor (AT1) is a 7-transmembrane domain GPCR that when activated by its ligand angiotensin II, generates signaling events promoting vascular dysfunction and the development of cardiovascular disease. Here, we show that the single-transmembrane oxidized LDL (oxLDL) receptor (LOX-1) resides in proximity to AT1 on cell-surface membranes and that binding of oxLDL to LOX-1 can allosterically activate AT1-dependent signaling events. oxLDL-induced signaling events in human vascular endothelial cells were abolished by knockdown of AT1 and inhibited by AT1 blockade (ARB). oxLDL increased cytosolic G protein by 350% in Chinese hamster ovary (CHO) cells with genetically induced expression of AT1 and LOX-1, whereas little increase was observed in CHO cells expressing only LOX-1. Immunoprecipitation and in situ proximity ligation assay (PLA) assays in CHO cells revealed the presence of cell-surface complexes involving LOX-1 and AT1. Chimeric analysis showed that oxLDL-induced AT1 signaling events are mediated via interactions between the intracellular domain of LOX-1 and AT1 that activate AT1. oxLDL-induced impairment of endothelium-dependent vascular relaxation of vascular ring from mouse thoracic aorta was abolished by ARB or genetic deletion of AT1. These findings reveal a novel pathway for AT1 activation and suggest a new mechanism whereby oxLDL may be promoting risk for cardiovascular disease. © FASEB.

Entities:  

Keywords:  G protein-coupled receptor; allosteric activation; receptor multimerization; vascular dysfunction

Mesh:

Substances:

Year:  2015        PMID: 25877213     DOI: 10.1096/fj.15-271627

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

Review 1.  The role of oxysterols in vascular ageing.

Authors:  Simona Gargiulo; Paola Gamba; Gabriella Testa; Gabriella Leonarduzzi; Giuseppe Poli
Journal:  J Physiol       Date:  2016-01-19       Impact factor: 5.182

2.  Mixed Vehicle Emissions Induces Angiotensin II and Cerebral Microvascular Angiotensin Receptor Expression in C57Bl/6 Mice and Promotes Alterations in Integrity in a Blood-Brain Barrier Coculture Model.

Authors:  Usa Suwannasual; JoAnn Lucero; Griffith Davis; Jacob D McDonald; Amie K Lund
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

3.  Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.

Authors:  Mohamed I Saad; Taha M Abdelkhalek; Moustafa M Saleh; Maher A Kamel; Mina Youssef; Shady H Tawfik; Helena Dominguez
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

4.  Angiotensin II induces the aggregation of native and oxidized low-density lipoprotein.

Authors:  Akira Sato; Chiemi Ueda; Ryu Kimura; Chisato Kobayashi; Yoji Yamazaki; Keiichi Ebina
Journal:  Eur Biophys J       Date:  2017-04-11       Impact factor: 1.733

5.  Oxidized low-density lipoprotein stimulates epithelial sodium channels in endothelial cells of mouse thoracic aorta.

Authors:  Chen Liang; Qiu-Shi Wang; Xu Yang; Na Niu; Qing-Qing Hu; Bao-Long Zhang; Ming-Ming Wu; Chang-Jiang Yu; Xiao Chen; Bin-Lin Song; Zhi-Ren Zhang; He-Ping Ma
Journal:  Br J Pharmacol       Date:  2017-06-13       Impact factor: 8.739

6.  MiR-27b augments bone marrow progenitor cell survival via suppressing the mitochondrial apoptotic pathway in Type 2 diabetes.

Authors:  Hainan Li; Jenny Liu; Yihan Wang; Zhiyao Fu; Maik Hüttemann; Terrence J Monks; Alex F Chen; Jie-Mei Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-11       Impact factor: 4.310

Review 7.  AT1 receptor signaling pathways in the cardiovascular system.

Authors:  Tatsuo Kawai; Steven J Forrester; Shannon O'Brien; Ariele Baggett; Victor Rizzo; Satoru Eguchi
Journal:  Pharmacol Res       Date:  2017-05-17       Impact factor: 7.658

Review 8.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

9.  Inhibition of Endocytosis of Clathrin-Mediated Angiotensin II Receptor Type 1 in Podocytes Augments Glomerular Injury.

Authors:  Kazunori Inoue; Xuefei Tian; Heino Velazquez; Keita Soda; Zhen Wang; Christopher E Pedigo; Ying Wang; Elizabeth Cross; Marwin Groener; Jee-Won Shin; Wei Li; Hossam Hassan; Koichi Yamamoto; Peter Mundel; Shuta Ishibe
Journal:  J Am Soc Nephrol       Date:  2019-09-11       Impact factor: 10.121

10.  Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System.

Authors:  Steven J Forrester; Tatsuo Kawai; Shannon O'Brien; Walter Thomas; Raymond C Harris; Satoru Eguchi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-11-09       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.